Lv11
26 积分 2024-09-17 加入
Accounting for correlation in network meta‐analysis with multi‐arm trials
7小时前
待确认
Accounting for correlation in network meta‐analysis with multi‐arm trials
8小时前
已完结
First‐line PD‐1/PD‐L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non‐squamous non‐small cell lung cancer: A Bayesian network meta‐analysis of randomized controlled trials
8小时前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
3个月前
已完结
Ivonescimab in non-small cell lung cancer: harmonizing immunotherapy and anti-angiogenesis
5个月前
已完结
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
6个月前
已完结
Indirect Comparison of Sintilimab and Other PD-L1 Inhibitors for First-Line Treatment of Non-Squamous Non-Small-Cell Lung Cancer
7个月前
已完结
Anti-Angiogenic Agents Combined with Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
8个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
8个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
9个月前
已完结
皖公网安备34019202002308
